acetaminophen has been researched along with Cardiovascular Diseases in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.35) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 18 (39.13) | 29.6817 |
2010's | 17 (36.96) | 24.3611 |
2020's | 9 (19.57) | 2.80 |
Authors | Studies |
---|---|
Ceravolo, GS; da Silva, DG; Gerardin, DCC; Klein, RM; Moreira, EG; Moura, KF; Novi, DRBS; Serafim, AFL; Vidigal, CB | 1 |
Djousse, L; Lei, G; Li, X; Rosenberg, L; Wei, J; Zeng, C; Zhang, Y | 1 |
Alchin, J; Christo, PJ; Dhar, A; Siddiqui, K | 1 |
FitzGerald, GA; Grosser, T; Spence, JD | 1 |
He, P; Liu, M; Qin, X; Wu, Q; Yang, S; Ye, Z; Zhang, Y; Zhou, C | 1 |
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
Canoy, D; Huang, J; Li, Y; Mamouei, M; Nazarzadeh, M; Neal, B; Rahimi, K; Rao, S; Salimi-Khorshidi, G; Schutte, AE; Smith, GD | 1 |
Kallistratos, MS; Manolis, AJ | 1 |
Dimassi, H; Kabbara, WK; Sheikh-Taha, M | 1 |
Dear, JW; MacIntyre, IM; McCrae, JC; Morrison, EE; Webb, DJ | 1 |
Pedersen, L; Schmidt, M; Sørensen, HT | 1 |
Achuff, BJ; Acosta, S; Checchia, PA; Lasa, JJ; Moffett, BS; Rusin, CG | 1 |
Fogleman, CD | 1 |
Richette, P | 1 |
Bernstein, I; Birrell, F; Buckner, S; Conaghan, PG; Constanti, M; Delgado Nunes, V; Doherty, M; Dziedzic, K; Latchem, S; Miller, P; Porcheret, M; Roberts, E; Wise, E; Zhang, W | 1 |
Wise, J | 1 |
Cricelli, C; Cricelli, I; Fanelli, A; Lapi, F; Lora Aprile, P; Piccinni, C; Roberto, G; Simonetti, M | 1 |
Bergmann, JF | 1 |
Amarenco, P; Bousser, MG; Chamorro, A; Fisher, M; Ford, I; Fox, KM; Gonzalez-Valcarcel, J; Hennerici, MG; Labreuche, J; Mattle, HP; Rothwell, PM; Sissani, L; Steg, PG; Vicaut, E | 1 |
Hermann, M | 1 |
Campbell, P; White, WB | 1 |
Nguyen, QV | 1 |
Anderson, S; Roth, SH | 1 |
Brune, K; Hinz, B | 1 |
Petersen, KU | 1 |
Alibhai, H; Baker, LA; Chang, YM; Davies, NA; Jalan, R; L Priestnall, S; Leckie, PJ; Lee, KC; Mookerjee, RP; Palacios Jimenez, C; Stanzani, G | 1 |
Buring, JE; Gaziano, JM; Glynn, RJ; Hennekens, CH; Kurth, T; Rexrode, KM; Stampfer, MJ; Walker, AM | 1 |
Blot, WJ; Friis, S; Johnsen, SP; Lipworth, L; McLaughlin, JK; Mellemkjaer, L; Nielsen, GL; Olsen, JH; Signorello, LB | 1 |
Farrell, M; McCormack, G; McCormick, PA; Treanor, D | 1 |
Brizendine, EJ; Furbee, RB; Kao, LW; Kirk, MA; Mehta, NH; Skinner, JR | 1 |
Buchanan, WW; Kean, WF | 1 |
Albert, CM; Chae, CU; Chan, AT; Curhan, GC; Fuchs, CS; Manson, JE; Rexrode, KM; Rimm, EB; Willett, WC | 1 |
Whelton, A | 1 |
Wilcox, CM | 1 |
Gaziano, JM; Gibson, CM | 1 |
Schnitzer, TJ | 1 |
Johnson, J; Weinryb, J | 1 |
Bertin, P | 1 |
Bertin, P; Dufauret-Lombard, C | 1 |
Camacho, ME; Paloski, WH; Reinertson, R; Warren, LE | 1 |
Johansson, S | 1 |
Gunn, VL; Liebelt, EL; Serwint, JR; Taha, SH | 1 |
Benhamou, JP; Rueff, B | 1 |
16 review(s) available for acetaminophen and Cardiovascular Diseases
Article | Year |
---|---|
Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older.
Topics: Acetaminophen; Acute Pain; Adult; Aged; Analgesics; Analgesics, Non-Narcotic; Asthma; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Kidney; Liver | 2022 |
Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Cardiovascular Diseases; Humans; Hypertension; Pain | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Long-term adverse effects of paracetamol - a review.
Topics: Acetaminophen; Acute Kidney Injury; Analgesics, Non-Narcotic; Asthma; Cardiovascular Diseases; Chronic Pain; Female; Humans; Incidence; Long-Term Care; Maternal Exposure; Neurodevelopmental Disorders; Observational Studies as Topic; Practice Guidelines as Topic; Pregnancy; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Risk Assessment | 2018 |
Paracetamol: not as safe as we thought? A systematic literature review of observational studies.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Cardiovascular Diseases; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Humans; Kidney Diseases; Mortality; Observational Studies as Topic | 2016 |
Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Case-Control Studies; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Humans; Meta-Analysis as Topic; Naproxen; Risk Assessment; Risk Factors | 2009 |
The NSAID dilemma: managing osteoarthritis in high-risk patients.
Topics: Acetaminophen; Administration, Oral; Adrenal Cortex Hormones; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Drug Interactions; Gastrointestinal Diseases; Humans; Hyaluronic Acid; Kidney Diseases; Osteoarthritis; Patient Selection; Proton Pump Inhibitors; Risk; Risk Factors | 2011 |
Paracetamol and cyclooxygenase inhibition: is there a cause for concern?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Blood Platelet Disorders; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Gastrointestinal Diseases; Humans | 2012 |
The use of NSAIDs in rheumatic disorders 2005: a global perspective.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Humans; Kidney; Kidney Diseases; Musculoskeletal Diseases; Prostaglandin-Endoperoxide Synthases; Rheumatic Diseases | 2005 |
Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease.
Topics: Acetaminophen; Aged; Aging; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Health Services for the Aged; Humans; Pain; Risk Factors | 2006 |
Gastrointestinal Considerations in Patients with Cardiovascular Disease Using Nonopioid Analgesics for Mild-to-Moderate Pain or Cardioprotection.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Gastrointestinal Hemorrhage; Humans; Pain; Risk Factors | 2006 |
Potential for drug-drug interactions in patients taking analgesics for mild-to-moderate pain and low-dose aspirin for cardioprotection.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Cardiotonic Agents; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Drug Administration Schedule; Drug Interactions; Humans; Ibuprofen; Pain | 2006 |
Update on guidelines for the treatment of chronic musculoskeletal pain.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Chronic Disease; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Humans; Musculoskeletal System; Pain; Practice Guidelines as Topic; Tramadol; United States; United States Food and Drug Administration | 2006 |
Safe pharmacologic treatment strategies for osteoarthritis pain in African Americans with hypertension, and renal and cardiac disease.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Black or African American; Cardiovascular Diseases; Comorbidity; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Kidney Diseases; Male; Osteoarthritis; Pain; United States | 2006 |
[What are the cardiovascular complications of the analgesics and glucocorticoids?].
Topics: Acetaminophen; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Buprenorphine; Cardiovascular Diseases; Clinical Trials as Topic; Codeine; Dextropropoxyphene; Glucocorticoids; Humans; Morphine; Nalbuphine; Nefopam; Risk Assessment; Risk Factors; Time Factors; Tramadol | 2006 |
Acute hepatic necrosis and fulminant hepatic failure.
Topics: Acetaminophen; Acute Disease; Alanine Transaminase; Animals; Blood Coagulation Disorders; Brain Diseases; Cardiovascular Diseases; Hepatitis; Humans; Ischemia; Jaundice; Kidney Diseases; Liver Diseases; Mycotoxins; Necrosis; Odorants; Prognosis; Prothrombin Time; Respiratory Insufficiency; Suicide; Sweating; Transaminases; Urine | 1973 |
2 trial(s) available for acetaminophen and Cardiovascular Diseases
Article | Year |
---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Implementation of the NASA Artificial Gravity Bed Rest Pilot Study.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Bed Rest; Bone Diseases; Cardiovascular Deconditioning; Cardiovascular Diseases; Centrifugation; Gravity, Altered; Head-Down Tilt; Humans; Male; Muscular Diseases; Pilot Projects; Program Evaluation; Research Design; Space Flight; Time Factors; United States; United States National Aeronautics and Space Administration; Weightlessness Countermeasures; Weightlessness Simulation | 2007 |
29 other study(ies) available for acetaminophen and Cardiovascular Diseases
Article | Year |
---|---|
Intrauterine and Lactational Exposure to Paracetamol: Cardiometabolic Evaluation in Adult Female and Male Offspring.
Topics: Acetaminophen; Adiposity; Analgesics, Non-Narcotic; Animals; Aorta, Thoracic; Cardiovascular Diseases; Female; Gestational Age; Hemodynamics; Insulin Resistance; Lactation; Male; Metabolic Diseases; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Risk Assessment | 2021 |
Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
Topics: Acetaminophen; Aged; Cardiovascular Diseases; Humans; Hypertension; Myocardial Infarction; Risk Factors; Sodium; Sodium, Dietary | 2022 |
Regular use of ibuprofen or paracetamol and incident type 2 diabetes: A prospective cohort study in the UK Biobank.
Topics: Acetaminophen; Adult; Biological Specimen Banks; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Humans; Ibuprofen; Incidence; Middle Aged; Prospective Studies; Risk Factors; United Kingdom | 2022 |
Cardiovascular risk from sodium-containing paracetamol products.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Cardiovascular Diseases; Heart Disease Risk Factors; Humans; Risk Factors; Sodium | 2022 |
Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
Topics: Acetaminophen; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Sodium; Sodium Bicarbonate | 2023 |
Deep learning approach to unmask hidden salt effects in the era of artificial intelligence.
Topics: Acetaminophen; Artificial Intelligence; Blood Pressure; Cardiovascular Diseases; Deep Learning; Humans; Sodium | 2023 |
Patterns of pain medication use in older individuals with cardiovascular disease.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Female; Gabapentin; Humans; Inappropriate Prescribing; Male; Neuralgia; Polypharmacy; Pregabalin; Retrospective Studies; Tramadol | 2018 |
Diclofenac use and cardiovascular risks: series of nationwide cohort studies.
Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cohort Studies; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Propensity Score; Risk Factors | 2018 |
Hypotensive Response to IV Acetaminophen in Pediatric Cardiac Patients.
Topics: Acetaminophen; Administration, Intravenous; Age Factors; Analgesics, Non-Narcotic; Blood Pressure; Cardiovascular Diseases; Child; Child, Preschool; Critical Illness; Female; Humans; Hypotension; Infant; Intensive Care Units, Pediatric; Male; Skin Temperature | 2019 |
Analgesics for osteoarthritis.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Osteoarthritis; Pain; Pain Measurement | 2013 |
How safe is acetaminophen in rheumatology?
Topics: Acetaminophen; Cardiovascular Diseases; Chronic Pain; Humans; Musculoskeletal Pain; Osteoarthritis; Risk Assessment | 2014 |
True risks of paracetamol may be underestimated, say researchers.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Cardiovascular Diseases; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Humans; Kidney Diseases; Review Literature as Topic | 2015 |
Risk of Acute Cerebrovascular and Cardiovascular Events Among Users of Acetaminophen or an Acetaminophen-Codeine Combination in a Cohort of Patients with Osteoarthritis: A Nested Case-Control Study.
Topics: Acetaminophen; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Codeine; Cohort Studies; Drug Combinations; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Osteoarthritis; Risk Factors | 2015 |
[Paracetamol: do we have to reconsider the benefit/risk ratio?].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Cardiovascular Diseases; Humans; Risk | 2015 |
Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Brain Ischemia; Cardiovascular Diseases; Female; Hemorrhage; Humans; Ibuprofen; Male; Middle Aged; Recurrence; Risk Factors; Stroke | 2016 |
Blood pressure destabilization on nonsteroidal antiinflammatory agents: acetaminophen exposed?
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypertension; Osteoarthritis; Pain; Risk Factors; Vasodilation | 2010 |
Letter by Nguyen regarding article, "Acetaminophen increases blood pressure in patients with coronary artery disease".
Topics: Acetaminophen; Analgesics, Non-Narcotic; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Hypertension; Risk Factors | 2011 |
[Basic drugs in pain therapy under discussion. How safe is paracetamol? (interview by Dr. Judith Neumaier)].
Topics: Acetaminophen; Analgesics; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Prescriptions; Germany; Humans; Liver Function Tests; Nonprescription Drugs; Risk Factors | 2011 |
A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival.
Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Animals; Biomarkers; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Critical Care; Disease Models, Animal; Disease Progression; Female; Hemodynamics; Intracranial Pressure; Liver; Liver Failure, Acute; Monitoring, Physiologic; Multiple Organ Failure; Necrosis; Renal Replacement Therapy; Reproducibility of Results; Respiration, Artificial; Swine; Time Factors | 2013 |
Analgesic use and change in kidney function in apparently healthy men.
Topics: Acetaminophen; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cohort Studies; Creatinine; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Physicians; Prospective Studies; Risk Factors; United States | 2003 |
A population-based cohort study of mortality among adults prescribed paracetamol in Denmark.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Cardiovascular Diseases; Cause of Death; Cerebrovascular Disorders; Cohort Studies; Data Interpretation, Statistical; Databases, Factual; Denmark; Diabetes Mellitus; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Neoplasms; Suicide | 2003 |
Early death from paracetamol (acetaminophen) induced fulminant hepatic failure without cerebral oedema.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Brain Edema; Cardiovascular Diseases; Cause of Death; Drug Overdose; Female; Heart Arrest; Humans; Hypotension; Incidence; Liver Failure; Male; Middle Aged | 2003 |
What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?
Topics: Acetaminophen; Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Cardiovascular Diseases; Child; Child, Preschool; Drug Eruptions; Drug Hypersensitivity; Drug Interactions; Drug Overdose; Female; Free Radical Scavengers; Histamine H1 Antagonists; Humans; Indiana; Infant; Infusions, Intravenous; Male; Middle Aged; Respiratory Tract Diseases; Retrospective Studies; Survival Analysis | 2003 |
Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events.
Topics: Acetaminophen; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Drug Evaluation; Female; Humans; Middle Aged; Prospective Studies; Risk; Risk Factors; Surveys and Questionnaires | 2006 |
Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Isoxazoles; Lactones; Pyrazoles; Risk Assessment; Sulfonamides; Sulfones | 2006 |
[What are the cardiovascular complications of the analgesics and glucocorticoids?].
Topics: Acetaminophen; Analgesics; Cardiovascular Diseases; Drug Prescriptions; Dyslipidemias; Glucocorticoids; Humans; Hypertension; Hypokalemia; Risk Factors | 2006 |
Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Gastrointestinal Diseases; Gout; Humans; Ibuprofen; Naproxen; Pain; Pyridines; Sulfones | 2007 |
Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine.
Topics: Acetaminophen; Animals; Antipyrine; Caffeine; Cardiovascular Diseases; Heart; Male; Myocardial Infarction; Myocardium; Necrosis; Phenacetin; Polyarteritis Nodosa; Rats; Rats, Inbred Strains; Splanchnic Circulation | 1981 |
Toxicity of over-the-counter cough and cold medications.
Topics: Acetaminophen; Antitussive Agents; Bradycardia; Brompheniramine; Cardiovascular Diseases; Child, Preschool; Drug Combinations; Drug Overdose; Fatal Outcome; Fever; Heart Arrest; Humans; Hypertension; Ibuprofen; Male; Nonprescription Drugs; Phenylephrine; Phenylpropanolamine; Pseudoephedrine; Sleep Stages; Tachycardia; Vomiting | 2001 |